Literature DB >> 18557727

New insights into mechanisms of spontaneous liver transplant tolerance: the role of Foxp3-expressing CD25+CD4+ regulatory T cells.

W Li1, C S Kuhr, X X Zheng, K Carper, A W Thomson, J D Reyes, J D Perkins.   

Abstract

Liver allografts in mice are accepted across MHC barriers without requirement for immunosuppressive therapy. The mechanisms underlying this phenomenon remain largely undefined. In this study, we investigated the role of Foxp3-expressing CD25(+)CD4(+) regulatory T cells (Treg) in the induction of murine liver transplant tolerance. Foxp3(+)CD25(+)CD4(+) T cells were increased in liver grafts and recipient spleens from day 5 to day 100 posttransplantation, associated with enhanced CTLA4 and TGF-beta expression and IL-4 production. Depletion of recipient CD25(+)CD4(+) T cells using anti-CD25 mAb (250 microg/day) induced acute liver allograft rejection. This was associated with a decreased ratio of Foxp3(+) Treg: T effector cells, decreased IL-4 and elevated IL-10 and IL-2 production by graft-infiltrating T cells, and reduced apoptotic activity of graft-infiltrating CD4(+) and CD8(+) T cells in anti-CD25-mAb-treated recipients. Thus, the data suggest that Foxp3(+)CD25(+)CD4(+)Treg are involved in spontaneous acceptance of liver allografts in mice. The ratio of Treg to T effector cells appears to determine liver transplant outcome. CTLA4, IL-4, TGF-beta and apoptosis of graft-infiltrating T cells are also associated with liver transplant tolerance and may contribute, at least in part, to the mechanisms of Treg-mediated immune regulation in this model.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18557727     DOI: 10.1111/j.1600-6143.2008.02300.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  56 in total

Review 1.  Why some organ allografts are tolerated better than others: new insights for an old question.

Authors:  Travis D Hull; Gilles Benichou; Joren C Madsen
Journal:  Curr Opin Organ Transplant       Date:  2019-02       Impact factor: 2.640

2.  Hepatobiliary quiz-7 (2013).

Authors:  Swastik Agrawal; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2013-09

Review 3.  Lessons and limits of mouse models.

Authors:  Anita S Chong; Maria-Luisa Alegre; Michelle L Miller; Robert L Fairchild
Journal:  Cold Spring Harb Perspect Med       Date:  2013-12-01       Impact factor: 6.915

Review 4.  Current status of immunosuppression in liver transplantation.

Authors:  Narendra S Choudhary; Sanjiv Saigal; Rajat Shukla; Hardik Kotecha; Neeraj Saraf; Arvinder S Soin
Journal:  J Clin Exp Hepatol       Date:  2013-06-03

Review 5.  Bioprinting an Artificial Pancreas for Type 1 Diabetes.

Authors:  Juewan Kim; Kyungwon Kang; Christopher J Drogemuller; Gordon G Wallace; P Toby Coates
Journal:  Curr Diab Rep       Date:  2019-07-04       Impact factor: 4.810

6.  Selective expansion of allogeneic regulatory T cells by hepatic stellate cells: role of endotoxin and implications for allograft tolerance.

Authors:  Anil Dangi; Tina L Sumpter; Shoko Kimura; Donna B Stolz; Noriko Murase; Giorgio Raimondi; Yoram Vodovotz; Chao Huang; Angus W Thomson; Chandrashekhar R Gandhi
Journal:  J Immunol       Date:  2012-03-16       Impact factor: 5.422

Review 7.  The liver works as a school to educate regulatory immune cells.

Authors:  Fenglei Li; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2013-04-22       Impact factor: 11.530

8.  Prevention of acute liver allograft rejection by IL-10-engineered mesenchymal stem cells.

Authors:  J Niu; W Yue; Y Song; Y Zhang; X Qi; Z Wang; B Liu; H Shen; X Hu
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

9.  A critical role of TRAIL expressed on cotransplanted hepatic stellate cells in prevention of islet allograft rejection.

Authors:  Horng-Ren Yang; Ching-Chuan Hsieh; Lianfu Wang; John J Fung; Lina Lu; Shiguang Qian
Journal:  Microsurgery       Date:  2010-05       Impact factor: 2.425

10.  DAP12 deficiency in liver allografts results in enhanced donor DC migration, augmented effector T cell responses and abrogation of transplant tolerance.

Authors:  O Yoshida; S Kimura; L Dou; B M Matta; S Yokota; M A Ross; D A Geller; A W Thomson
Journal:  Am J Transplant       Date:  2014-06-16       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.